Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

American Urological Association In Brief

This article was originally published in The Tan Sheet

Executive Summary

"Herbal Viagra" risk: Herbal products marketed as erectile dysfunction treatments should be monitored for potentially toxic pharmacologic concentrations of PDE5 inhibitors, according to study presented at American Urological Association meeting in San Francisco May 10. Neil Fleshner, MD, et al. found significant contamination with sildenafil and tadalafil in two of seven herbal brands marketed for ED treatment. Consumers and regulatory agencies "must be aware of these findings as these agents have known fatal interactions with prevalently consumed drugs (e.g. nitrates)," according to the study. Researchers say the findings "seriously challenge the concept of safety of CAM (complimentary alternative medicine) agents" and recommend "tighter regulation of CAM marketed preparations"...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS096816

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel